title: Effects of the combination of metyrapone and oxazepam on cocaine-induced increases in corticosterone in the medial prefrontal cortex and nucleus accumbens.
abstract: We have previously demonstrated that a combination of drugs (i.e., metyrapone and oxazepam) known to attenuate HPA-axis activity effectively decreases cocaine self-administration and cue reactivity in rats. However, we did not find changes in plasma corticosterone that matched the behavioral effects we observed, indicating that a different mechanism of action must be involved. Therefore, we hypothesized that the combination of metyrapone and oxazepam attenuates cocaine taking and seeking by decreasing cocaine-induced increases in corticosterone in the brain. Male rats were implanted with guide cannulae targeting the medial prefrontal cortex or nucleus accumbens. After the rats recovered from surgery, the microdialysis session was conducted. Rats were housed in the experimental chamber and the dialysis probes inserted into the guide cannulae the night before the session. The following day, dialysate samples were collected over a five-hour session. Baseline samples were collected for the first two hours, every 20min. Samples were then collected following administration of cocaine (15mg/kg, ip). Before injections of cocaine, rats were pretreated with either vehicle or the combination of metyrapone (50mg/kg, ip) and oxazepam (10mg/kg, ip). The administration of cocaine resulted in an increase in corticosterone in the medial prefrontal cortex following vehicle pretreatment, which was not observed in the nucleus accumbens. This cocaine-induced increase in corticosterone was attenuated by metyrapone/oxazepam. Reducing cocaine-induced increases in corticosterone in the medial prefrontal cortex might represent a novel mechanism through which the combination of metyrapone/oxazepam produces its behavioral effects.
authors.affiliation: Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center, Shreveport, LA 71130, United States. Electronic address: ckell1@lsuhsc.edu.
authors.forename: Courtney M
authors.initials: CM
authors.lastname: Keller
authors.affiliation: Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center, Shreveport, LA 71130, United States.
authors.forename: Kelly N
authors.initials: KN
authors.lastname: Breaux
authors.affiliation: Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center, Shreveport, LA 71130, United States.
authors.forename: Nicholas E
authors.initials: NE
authors.lastname: Goeders
mesh_terms: D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D003345:Corticosterone / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018757:GABA Modulators / Q000494:pharmacology; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000378:metabolism; D010076:Oxazepam / Q000494:pharmacology*; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018765:Dopamine Uptake Inhibitors; D004791:Enzyme Inhibitors; D018757:GABA Modulators; D010076:Oxazepam; D003042:Cocaine; D003345:Corticosterone; D008797:Metyrapone
keywords: Cocaine; In vivo microdialysis; Medial prefrontal cortex; Metyrapone; Nucleus accumbens; Oxazepam